• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Volastra

hawaii parasail ocean
Biotech

20-year Novo vet lands first CEO role—Chutes & Ladders

20-year Novo vet lands first CEO role. Acadia bulks up rare disease digs with BMS vet. EpiVax bags Big Pharma vet as CSO.
Darren Incorvaia , Zoey Becker May 30, 2025 8:30am
Cell division process

Volastra taps CSO as it looks to expand research horizons

Oct 16, 2024 7:00am
Transparent cells with nucleus cell membrane and visible chromosomes

Mitochondrial free radicals spur micronuclear collapse in cancer

Aug 29, 2024 2:00pm
cash runway cash airplane extend deal earnings

Volastra buys clinical cancer med from Amgen, tacks on $60M

Mar 7, 2023 7:00am
Fierce Biotech Fierce 15 logo

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am
graphic of a man with money identifying new ideas

Arch raises nearly $3B amid cratering biotech market

Jun 29, 2022 11:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings